Full Press Release Details
Immatics Announces Pricing of $150 Million Public Offering.
IMTX
Immatics Announces Pricing of $150 Million Public Offering
Key Takeaway: Immatics Announces Pricing of $150 Million Public Offering
Price reaction · baseline $9.345 (2024-10-10 close) · hit after-hours · clean, no other IMTX news in the window
day 0 close
-0.1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+20%
120-day peak, hindsight
Typical move
3.9%
average across 7 past catalysts
Lead asset
IMA401
Phase 1 · Refractory Cancer